Home・Lista de Ações・Design Therapeutics Inc

Design Therapeutics Inc

Fechado

10.14 5.3

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

10.11

Máximo

10.26

Indicadores-chave
By Trading Economics
Rendimento	-2.5M -20M
EPS	-0.32
Funcionários	55
EBITDA	-4.5M -22M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+113.03% upside

Dividendos
By Acuity
Próximos Ganhos	10 de nov. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-107M 635M
Abertura anterior	4.84
Fecho anterior	10.14

Design Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

7 de nov. de 2026, 22:42 UTC

UK Retail Sales Monitor Set for Release Amid Cautious Sentiment and Mixed Economic Signals

7 de nov. de 2026, 22:42 UTC

Mexico's Inflation Rate YoY Expected to Rise Ahead of November 9 Release, Heightening Concerns Over Persistent Price Pressures and Potential Monetary Policy Adjustments.

7 de nov. de 2026, 22:11 UTC

Mexico's Upcoming Inflation Rate Release on November 9, 2026, Sparks Caution Amid Global Economic Concerns.

7 de nov. de 2026, 22:11 UTC

Japan's Current Account Surplus Forecasted at JPY 3.35 Trillion Amidst Cautious Market Sentiment Following Nikkei Index Plunge

7 de nov. de 2026, 22:01 UTC

Spanish Consumer Confidence Index Release on November 10, 2026, Amid Rising Concerns Over Geopolitical Tensions and Inflationary Pressures.

7 de nov. de 2026, 21:52 UTC

Japan's Household Spending Expected to Decline 3.1% YoY Amid Economic Challenges and Market Skepticism

7 de nov. de 2026, 21:52 UTC

Australia's Westpac Consumer Confidence Index set for release on November 9, amid global inflation concerns and tech market volatility.

7 de nov. de 2026, 21:52 UTC

Australia's Westpac Consumer Confidence Index set for release amid global market volatility and cautious sentiment ahead of key economic data.

7 de nov. de 2026, 21:52 UTC

Japan's Household Spending MoM data for September set to release on November 9, with a modest forecast increase of 0.3% amid cautious market sentiment and recent declines in the Nikkei index.

7 de nov. de 2026, 21:52 UTC

UK GDP 3-Month Average Data Release on November 12 Sparks Cautious Optimism Amid Economic Uncertainties.

7 de nov. de 2026, 21:43 UTC

India's Inflation Rate Expected to Rise to 5.93% in October Amidst Geopolitical Tensions and Positive Equity Market Sentiment

7 de nov. de 2026, 21:43 UTC

South Korea's October 2026 unemployment rate release on November 10 expected to reflect ongoing positive employment trends amid global market volatility.

7 de nov. de 2026, 21:33 UTC

Euro Area Expected to Report €4.5 Billion Trade Deficit Amid Weak Retail Sales and Rising Inflation Concerns

7 de nov. de 2026, 21:33 UTC

Euro Area Employment Change Report Forecasts 0.2% Increase Amid Global Labor Market Optimism and Inflation Concerns

7 de nov. de 2026, 21:23 UTC

Brazil's Central Bank to Provide Key Insights on Interest Rates Amid Global Economic Pressures in Upcoming November 9 Readout.

7 de nov. de 2026, 21:03 UTC

API Crude Oil Stock Change Report on November 10 Expected Amid Geopolitical Tensions and Volatile WTI Prices at $90 per Barrel.

7 de nov. de 2026, 20:41 UTC

The CHF/JPY currency pair remains stable near the upper end of its one-month trading range, following Friday's strong U.S. non-farm payroll report.

7 de nov. de 2026, 20:41 UTC

The EUR/SEK currency pair is roughly flat since Friday's close, amid speculation about potential interest rate hikes following recent U.S. labor market data.

7 de nov. de 2026, 20:41 UTC

GBP/CAD remained roughly flat over the weekend, positioned near the upper end of its one-month trading range amid speculation of potential Fed interest rate hikes.

7 de nov. de 2026, 20:41 UTC

The EUR/JPY currency pair has seen a slight increase since Friday's close, remaining stable during the weekend market closure.

7 de nov. de 2026, 20:41 UTC

The EUR/NZD currency pair is lower since Friday's close, amid speculation of potential U.S. interest rate hikes following strong labor market data.

7 de nov. de 2026, 20:41 UTC

Macro News

The IBEX 35 Index is declining during after-market hours amid regulatory concerns in the pharmaceutical sector and fears of tighter AI regulations.

7 de nov. de 2026, 20:33 UTC

China's Q3 2026 Current Account Release Expected to Show Continued Strong Surplus Amid Positive Trade Dynamics

7 de nov. de 2026, 20:33 UTC

Italy's Balance of Trade data set for November 13 reveals a forecasted surplus of €1.85 billion amid cautious market sentiment and concerns over rising energy costs impacting trade dynamics.

7 de nov. de 2026, 20:03 UTC

South Africa's Q3 2026 Unemployment Rate Release on November 10 Expected Amidst High Rates and Global Job Market Concerns.

7 de nov. de 2026, 19:53 UTC

Italy's Industrial Production Expected to Grow 0.7% MoM Amid Mixed European Economic Sentiment Ahead of November Release

7 de nov. de 2026, 19:33 UTC

UK Q3 2026 GDP Growth Rate Release on November 12 Expected at 0.7% Amid Investor Caution Over Geopolitical Uncertainties and Inflationary Pressures.

7 de nov. de 2026, 19:33 UTC

UK Goods Trade Balance Expected to Widen Deficit to -19.2 Billion GBP Amid Economic and Geopolitical Pressures

7 de nov. de 2026, 19:33 UTC

UK Monthly GDP MoM Release on November 12 Forecasts No Growth Amid Cautious Optimism and Inflation Concerns.

7 de nov. de 2026, 19:33 UTC

UK's Non-EU Goods Trade Balance Data Set for Release on November 12, Expected to Reflect International Trade Trends Amid Cautious Market Sentiment.

Comparação entre Pares

Variação de preço

Design Therapeutics Inc Previsão

Preço-alvo

By TipRanks

113.03% parte superior

Previsão para 12 meses

Média 21.75 USD 113.03%

Máximo 26 USD

Mínimo 19 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Design Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

Comprar

Manter

Vender

Com base em 4 analistas que deram avaliações de ações para Design Therapeutics Inc - Dist nos últimos 3 meses.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.